Wide Ranks

CSBR

Champions Oncology, Inc.

4.31

Top Statistics
Market Cap 58 M Forward PE 22.68 Revenue Growth 11.90 %
Current Ratio 0.69 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -6.58 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -53.73 Enterprise / Revenue 1.22 Price To Sales Trailing12 Months 1.13
Profitability
Profit Margins -6.58 % Operating Margins 9.45 %
Balance Sheet
Total Cash 2 M Total Cash Per Share 0.2130 Total Debt 7 M
Total Debt To Equity Current Ratio 0.69 Book Value Per Share -0.0240
All Measures
Short Ratio 1841.00 % Message Board Id finmb_323655 Shares Short Prior Month 200104
Return On Equity -4.32 City Hackensack Uuid e627bf72-f175-3648-90e3-812092d24641
Previous Close 4.30 First Trade Date Epoch Utc 1 B Book Value -0.0240
Beta 0.4930 Total Debt 7 M Volume 1131
Last Split Date 1 B Fifty Two Week Low 3.60 Total Cash Per Share 0.2130
Total Revenue 51 M Shares Short Previous Month Date 1 B Target Median Price 6.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins 9.45 %
Target Mean Price 6.00 Net Income To Common -3397000 Short Percent Of Float 0.0408
Implied Shares Outstanding 13 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 9010 Average Volume10days 9010 Total Cash 2 M
Next Fiscal Year End 1 B Revenue Per Share 3.81 Held Percent Insiders 0.2633
Ebitda Margins -2.26 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 4.30 Target Low Price 6.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.44 Open 4.32
Free Cashflow -837500 State NJ Dividend Yield 0.00 %
Return On Assets -0.0693 Time Zone Short Name EST Trailing Eps -0.2600
Day Low 4.18 Address1 One University Plaza Shares Outstanding 13 M
Price Hint 4 Target High Price 6.00 Website https://www.championsoncology.com
52 Week Change -0.1631 Average Volume 54779 Forward Eps 0.1900
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 62.20 %
Last Split Factor 1:12 Regular Market Day High 4.32 Is_sp_500 False
Profit Margins -6.58 % Fifty Two Week High 7.13 Day High 4.32
Shares Short 224452 Regular Market Open 4.32 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 1.22 Revenue Growth 11.90 %
Shares Percent Shares Out 0.0165 Operating Cashflow -1835000 Currency USD
Time Zone Full Name America/New_York Market Cap 58 M Is_nasdaq_100 False
Zip 07601 Quote Type EQUITY Industry Biotechnology
Long Name Champions Oncology, Inc. Regular Market Day Low 4.18 Held Percent Institutions 0.4909
Current Price 4.31 Address2 Suite 307 Enterprise To Ebitda -53.73
Financial Currency USD Current Ratio 0.69 Gross Margins 44.27 %
Industry Disp Biotechnology Number Of Analyst Opinions 1 Country United States
Float Shares 4 M Two Hundred Day Average 4.81 Enterprise Value 62 M
Price To Sales Trailing12 Months 1.13 Forward PE 22.68 Regular Market Volume 1131
Ebitda -1169000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.

The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice.

It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies.

The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies.

Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011.

The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.